Abstract:INTRODUCTION The understanding of the pathological events in Alzheimer's disease (AD) has advanced dramatically, but the successful translation from rodent models into efficient human therapies is still problematic. METHODS To examine how tau pathology can develop in the primate brain, we injected 12 macaques with a dual tau mutation (P301L/S320F) into the entorhinal cortex (ERC). An investigation was performed using high‐resolution microscopy, magnetic resonance imaging (MRI), positron emission tomography (PET), and fluid biomarkers to determine the temporal progression of the pathology 3 and 6 months after the injection. RESULTS Using quantitative microscopy targeting markers for neurodegeneration and neuroinflammation, as well as fluid and imaging biomarkers, we detailed the progression of misfolded tau spreading and the consequential inflammatory response induced by glial cells. DISCUSSION By combining the analysis of several in vivo biomarkers with extensive brain microscopy analysis, we described the initial steps of misfolded tau spreading and neuroinflammation in a monkey model highly translatable to AD patients. Highlights Dual tau mutation delivery in the entorhinal cortex induces progressive tau pathology in rhesus macaques. Exogenous human 4R‐tau coaptates monkey 3R‐tau during transneuronal spread, in a prion‐like manner. Neuroinflammatory response is coordinated by microglia and astrocytes in response to tau pathology, with microglia targeting early tau pathology, while astrocytes engaged later in the progression, coincident with neuronal death. Monthly collection of CSF and plasma revealed a profile of changes in several AD core biomarkers, reflective of neurodegeneration and neuroinflammation as early as 1 month after injection.

A novel tau‐based rhesus monkey model of Alzheimer's pathogenesis

Temporal progression of tau pathology and neuroinflammation in a rhesus monkey model of Alzheimer's disease

Rhesus monkeys as a translational model for late‐onset Alzheimer's disease

Towards developing a rhesus monkey model of early Alzheimer's disease focusing on women's health

A nonhuman primate model with Alzheimer's disease-like pathology induced by hippocampal overexpression of human tau

Stabilizing the Retromer Complex in a Human Stem Cell Model of Alzheimer’s Disease Reduces TAU Phosphorylation Independently of Amyloid Precursor Protein

A novel rhesus macaque model of Huntington’s disease recapitulates key neuropathological changes along with progressive motor and cognitive decline

Tauopathy promotes spinal cord-dependent production of toxic amyloid-beta in transgenic monkeys

Pathological Markers of Alzheimer's Disease and Related Dementia in the Rhesus Macaque Amygdala

Tau, synapse loss and gliosis progress in an Alzheimer's mouse model after amyloid-β immunotherapy

A nonhuman primate model of early Alzheimer's disease pathologic change: Implications for disease pathogenesis

Synthetic amyloid-β oligomers drive early pathological progression of Alzheimer’s disease in nonhuman primates

Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation models

Aging African green monkeys manifest transcriptional, pathological, and cognitive hallmarks of human Alzheimer's disease

A novel tauopathy model mimicking molecular and spatial aspects of human tau pathology

Early blood immune molecular alterations in cynomolgus monkeys with a PSEN1 mutation causing familial Alzheimer's disease

Bearded capuchin monkeys as a model for Alzheimer's disease

appear resistant to trans-synaptic tau propagation

Aged rhesus monkeys: Cognitive performance categorizations and preclinical drug testing

Human Alzheimer's Disease ATN/ABC Staging Applied to Aging Rhesus Macaque Brains: Association With Cognition and MRI‐Based Regional Gray Matter Volume

A Novel Transgenic Mouse Line with Hippocampus-Dominant and Inducible Expression of Truncated Human Tau